tradingkey.logo

Pfizer Inc

PFE
View Detailed Chart

25.140USD

+0.030+0.12%
Close 08/15, 16:00ETQuotes delayed by 15 min
142.92BMarket Cap
18.13P/E TTM

Pfizer Inc

25.140

+0.030+0.12%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.12%

5 Days

+2.28%

1 Month

+2.15%

6 Months

-1.53%

Year to Date

-5.24%

1 Year

-12.43%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 26 analysts
HOLD
Current Rating
29.227
Target Price
16.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

177
Total
5
Median
8
Average
Company name
Ratings
Analysts
Pfizer Inc
PFE
26
Biogen Inc
BIIB
37
Alnylam Pharmaceuticals Inc
ALNY
34
Vertex Pharmaceuticals Inc
VRTX
34
Amgen Inc
AMGN
33
AbbVie Inc
ABBV
28
1
2
3
...
36

Pfizer Inc Trading Strategy

Short Term

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(1)
Neutral(2)
Buy(7)
Indicators
Sell(1)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.228
Neutral
RSI(14)
57.569
Neutral
STOCH(KDJ)(9,3,3)
90.522
Overbought
ATR(14)
0.540
High Vlolatility
CCI(14)
113.643
Buy
Williams %R
7.306
Overbought
TRIX(12,20)
-0.025
Sell
StochRSI(14)
94.113
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
24.928
Buy
MA10
24.566
Buy
MA20
24.488
Buy
MA50
24.542
Buy
MA100
23.892
Buy
MA200
25.086
Buy

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.
Ticker SymbolPFE
CompanyPfizer Inc
CEODr. Albert Bourla, Ph.D.
Websitehttps://www.pfizer.com/
KeyAI